0001609351-17-000061.txt : 20170621
0001609351-17-000061.hdr.sgml : 20170621
20170621164411
ACCESSION NUMBER: 0001609351-17-000061
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170619
FILED AS OF DATE: 20170621
DATE AS OF CHANGE: 20170621
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spark Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609351
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462654405
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: 888-772-7560
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: High Katherine A
CENTRAL INDEX KEY: 0001631248
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36819
FILM NUMBER: 17923276
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
4
1
wf-form4_149807783601601.xml
FORM 4
X0306
4
2017-06-19
0
0001609351
Spark Therapeutics, Inc.
ONCE
0001631248
High Katherine A
C/O SPARK THERAPEUTICS, INC.
3737 MARKET STREET, SUITE 1300
PHILADELPHIA
PA
19104
1
1
0
0
See Remarks
Common Stock
2017-06-19
4
M
0
10000
3.45
A
220000
D
Common Stock
2017-06-19
4
S
0
10000
60
D
210000
D
Stock Option (right to buy)
3.45
2017-06-19
4
M
0
10000
0
D
2024-07-02
Common Stock
10000.0
118249
D
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2017.
This option was granted on July 2, 2014 and vests over four years, with 25% of the shares underlying the option vesting on May 24, 2015, and the remainder vesting quarterly thereafter.
President and Chief Scientific Officer
/s/ Joseph W. La Barge, attorney-in-fact for Katherine A. High
2017-06-21